Find News

Filter articles

Showing 3171 to 3180 of 3417 results

Schiff Hardin expands IP litigation team


Schiff Hardin LLP has expanded its IP group with the hiring of Imron Aly as a partner.

Actavis wins Lialda generic appeal

US02-04-2014Legal developments

The US Court of Appeals for the Federal Circuit has reversed a lower court decision that found Actavis’s generic version of Shire’s ulcerative colitis drug Lialda (mesalamine) infringes US patent 6,773,720.

Lilly beats back challenge to Alimta patent

US01-04-2014Legal developments

The US District Court for the Southern District of Indiana has upheld a patent covering Eli Lilly’s second biggest drug Alimta (pemetrexed disodium), after a challenge by Teva’s US pharmaceutical arm.

US Supreme Court agrees to hear Copaxone appeal

India, Israel, US01-04-2014Legal developments

The US Supreme Court has agreed to hear Teva’s appeal against a Federal Circuit decision that invalidated a patent covering its $4.3 billion-a-year Copaxone (glatiramer acetate) drug, allowing Sandoz, Mylan and Natco to produce generic versions.

Novartis launches Gleevec action against Dr. Reddy’s

US28-03-2014Legal developments

Novartis has sued generic drugmaker Dr. Reddy’s Laboratories for infringing a patent related to its chronic myelogenous leukaemia drug Gleevec/Glivec (imatinib mesylate).

Proposed US bill could allow extensions on biologics patent terms


Three US lawmakers have introduced legislation that, if passed, would allow patent owners to obtain protection for existing biologic drugs that have been approved for new indications.

Gilead’s attempt to patent Sovaldi in India opposed

India, US26-03-2014

Gilead Sciences has received another challenge to its application to patent its new hepatitis C drug Sovaldi (sofosbuvir) in India.

Mylan fights off Teva’s Perforomist challenge

US25-03-2014Legal developments

The US District Court for the Northern District of West Virginia has upheld the validity of four patents covering Mylan’s Perforomist (formoterol fumarate) inhalation solution.

Stem cell patent indicates support for regenerative medicine research


The USPTO has issued a patent to Israeli biotechnology company BrainStorm Cell Therapeutics, which covers stem cell technology that can be used in the treatment of neurodegenerative diseases such as Parkinson’s and Alzheimer’s.

EPO staff set to strike for seven days


Staff at the European Patent Office will hold seven days of strike action starting this week, it has been confirmed.

Showing 3171 to 3180 of 3417 results